Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-2-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-40
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1478154-Aged,
pubmed-meshheading:1478154-Arteriosclerosis Obliterans,
pubmed-meshheading:1478154-Diabetes Mellitus, Type 2,
pubmed-meshheading:1478154-Diabetic Angiopathies,
pubmed-meshheading:1478154-Eicosapentaenoic Acid,
pubmed-meshheading:1478154-Female,
pubmed-meshheading:1478154-Hemodynamics,
pubmed-meshheading:1478154-Humans,
pubmed-meshheading:1478154-Male
|
pubmed:year |
1992
|
pubmed:articleTitle |
Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
|
pubmed:publicationType |
Letter
|